A carregar...
HER2 testing to manage patients with breast cancer or other solid tumors.
OBJECTIVES: Systematic review of trastuzumab outcomes among breast cancer patients who have negative, equivocal, or discordant HER2 assay results; use of HER2 assay results to predict outcomes of chemotherapy or hormonal therapy regimen for breast cancer; use of serum HER2 to monitor treatment respo...
Na minha lista:
| Publicado no: | Evid Rep Technol Assess (Full Rep) |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
United States. Agency for Healthcare Research and Quality
2008
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4781031/ https://ncbi.nlm.nih.gov/pubmed/19408965 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|